https://seekingalpha.com/article/4802442-eli-lilly-competition-melts-away
0
0
35 words
0
Comments
Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on my Strong Buy rating for LLY.
You are the first to view
Create an account or login to join the discussion